AC Immune SA ACIU
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -47.95% | -89.86% | 14.13% | 5.99% |
| Total Depreciation and Amortization | -- | 23.06% | 13.08% | 6.41% | 0.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -16.46% | -67.65% | -82.84% | 58.74% |
| Change in Net Operating Assets | -- | -106.91% | -71.62% | -96.05% | 1,731.75% |
| Cash from Operations | -- | -215.34% | -218.43% | -201.75% | 204.92% |
| Capital Expenditure | -- | -61.32% | -38.63% | -33.35% | 19.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 167.73% | 163.55% | 134.09% | -101,505.99% |
| Cash from Investing | -- | 166.47% | 161.85% | 132.28% | -8,234.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -50.22% | -43.93% | -37.70% | -32.59% |
| Issuance of Common Stock | -- | -94.89% | -99.98% | -99.99% | -99.69% |
| Repurchase of Common Stock | -- | 96.15% | -2,400.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 99.82% | 99.81% | 94.20% |
| Cash from Financing | -- | 3.84% | -102.49% | -102.20% | -101.62% |
| Foreign Exchange rate Adjustments | -- | -80.08% | 85.18% | -56.17% | -1,978.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 79.68% | -2,917.84% | -325.00% | -7,989.77% |